返回 Agenda
Session 6, Tracks C: Patient Centricity as a Key Component for Successful Pharmacovigilance Strategies (Part I)
Session Chair(s)
Raphael Elmadjian Pareschi, PharmD, MBA
Patient Safety Lead/ Head of Pharmacovigilance Brazil
Roche, Brazil
Bianca Passos, MBA, RPh
Country Safety Head - Brazil
Sanofi, Brazil
This session is part one of a two-part session that will include a comprehensive overview of the importance of involving the patient to gather insights and sharp decision-making to enable the safe use of medicines. Attendees will gain insights from industry and regulators on this topic to highlight the importance of putting the patient at the center of what we do throughout the product’s lifecycle in relation to effective risk mitigation.
Learning Objective : At the conclusion of this session, participants should be able to:- Recognize the importance of input from patients for effective decision-making strategies for pharmacovigilance
- Discuss effective strategies for risk communication, how to combat misinformation to enable stakeholders to make informed decisions and improve their experience with the use of medicinal products
- Describe examples of successful patient centric initiatives in risk communication
Speaker(s)
Patient´s Voice into the Development of Risk Minimization Materials (Ophtalmology Treatment)
Cristiane Carvalho, MBA
Roche, Brazil
Patient Safety Team Leader
Patient Centricity as a Key Component for Successful Pharmacovigilance Strategies
Johan Beun, MPA
Markiva, Netherlands
Coordinator/Manager
Patient Involvement in Patient Labeling and Additional Risk Minimization Materials: Recommendations from the CIOMS Working Group XI
Meredith Smith, PhD, MPA, FISPE
Evidera, Inc, United States
Senior Director, Implementation Science Pillar Lead